{"id":"licensed-rsv-vaccine","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This vaccine works by introducing a piece of the RSV virus to the body, which triggers an immune response and the production of antibodies to fight the virus.","oneSentence":"Stimulates the immune system to produce antibodies against RSV","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T02:42:45.488Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Respiratory Syncytial Virus (RSV) infection"}]},"trialDetails":[{"nctId":"NCT06813872","phase":"","title":"Effectiveness of ABRYSVO® Maternal Respiratory Syncytial Virus (RSV) Vaccine Against RSV in Infants in Western Pennsylvania","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pfizer","startDate":"2025-02-24","conditions":"Respiratory Syncytial Viruses","enrollment":1},{"nctId":"NCT07117487","phase":"PHASE3","title":"A Study of mRNA-1345 Following a Primary Dose of a Licensed Protein Subunit Respiratory Syncytial Virus (RSV) Vaccine in Adult Participants ≥60 Years of Age","status":"ACTIVE_NOT_RECRUITING","sponsor":"ModernaTX, Inc.","startDate":"2025-08-05","conditions":"Respiratory Syncytial Virus","enrollment":507},{"nctId":"NCT07185399","phase":"PHASE4","title":"Systems Biological Analysis of Immune Responses to RSV Vaccine","status":"ACTIVE_NOT_RECRUITING","sponsor":"Emory University","startDate":"2025-10-13","conditions":"Respiratory Syncytial Virus (RSV)","enrollment":14},{"nctId":"NCT06686654","phase":"PHASE1, PHASE2","title":"Study of a Human Metapneumovirus/Respiratory Syncytial Virus mRNA Vaccine Candidate Encapsulated in a Lipid Nanoparticle-based Formulation in Adults Aged 60 Years and Older","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2024-11-11","conditions":"Human Metapneumovirus Immunization, Respiratory Syncytial Virus Immunization","enrollment":1530},{"nctId":"NCT06077149","phase":"PHASE4","title":"Immunogenicity of RSV Vaccines in Residents of Long-Term Care Facilities (LTCF)","status":"COMPLETED","sponsor":"University of Rochester","startDate":"2023-11-07","conditions":"Respiratory Syncytial Virus (RSV)","enrollment":152},{"nctId":"NCT06481579","phase":"PHASE2","title":"A Study of IVX-A12 in Adults Participants","status":"COMPLETED","sponsor":"Icosavax, Inc.","startDate":"2024-06-10","conditions":"Healthy Participants","enrollment":143},{"nctId":"NCT05886777","phase":"PHASE2","title":"A Study to Learn About Two or More Vaccines That Are Put Together as One Shot Against Infectious Lung Illnesses, Including COVID-19 and Respiratory Syncytial Virus (RSV).","status":"COMPLETED","sponsor":"Pfizer","startDate":"2023-06-05","conditions":"Healthy Participants","enrollment":1142},{"nctId":"NCT05169905","phase":"PHASE3","title":"A Study to Evaluate the Safety and Immune Response to an Unadjuvanted RSV Maternal Vaccine in Healthy Non-pregnant Females From 9 to 49 Years of Age","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2022-02-02","conditions":"Respiratory Syncytial Virus Infections","enrollment":9},{"nctId":"NCT01709019","phase":"PHASE1","title":"RSV-F Vaccine and Influenza Vaccine Co-Administration Study in the Elderly","status":"COMPLETED","sponsor":"Novavax","startDate":"2012-10","conditions":"Respiratory Syncytial Virus (RSV)","enrollment":220}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":29,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["AREXVY"],"phase":"phase_2","status":"active","brandName":"Licensed RSV Vaccine","genericName":"Licensed RSV Vaccine","companyName":"Sanofi Pasteur, a Sanofi Company","companyId":"sanofi","modality":"Biologic","firstApprovalDate":"","aiSummary":"Stimulates the immune system to produce antibodies against RSV Used for Respiratory Syncytial Virus (RSV) infection.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}